Janelle Sauvageau

Title: Janelle Sauvageau: Innovator in Immunomodulation

Introduction

Janelle Sauvageau is a prominent inventor based in Ottawa, Canada. She has made significant contributions to the field of immunology, particularly through her innovative research and patented inventions. With a total of 3 patents, her work focuses on the modulation of immune responses, which has important implications for therapeutic applications.

Latest Patents

One of her latest patents is titled "Use of phosphorylated heptose compounds." This invention highlights the utility of phosphorylated heptose compounds in modulating immune responses in subjects. Additionally, these compounds serve as effective adjuvants. Another notable patent is "D-glycero-B-D-heptose 1-phosphate conjugates and use for targeted immune modulation." This patent describes heptose-1-monophosphate-7-derivatives as modifiable immunomodulators that can be utilized to prepare clinically active conjugate compounds, which are beneficial in modulating immune responses.

Career Highlights

Throughout her career, Janelle has worked with esteemed organizations such as the National Research Council of Canada and the University of Toronto. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Janelle has collaborated with notable colleagues, including Andrew Cox and Scott D Gray-Owen. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.

Conclusion

Janelle Sauvageau's innovative work in immunomodulation showcases her dedication to advancing scientific knowledge and therapeutic applications. Her patents reflect her commitment to improving immune response modulation, making her a valuable contributor to the field.